APPLIED NEUROSOLUTIONS

Applied NeuroSolutions, Inc., a development stage biopharmaceutical company, focuses on the development of therapeutic targets for the treatment of Alzheimer's disease (AD) and diagnostics to detect AD. It also develops cerebrospinal fluid-based and serum-based tests to detect AD at an early stage. The company also markets a transgenic mouse comprising the human tau gene that develops human paired helical filaments, the building blocks of the neurofibrillary tangles, which are involved in the pathology of Alzheimer’s disease; and provides diagnostic services to pharmaceutical companies. Ophidian Pharmaceuticals is a division of Applied NeuroSolutions Inc. Source: [Bloomberg Businessweek]